Mereo Biopharma Group Plc ADR (NASDAQ:MREO) shares, rose in value, with the stock price down by -2.49% to the previous day’s close as strong demand from buyers drove the stock to $2.74.
Actively observing the price movement in the last trading, the stock closed the session at $2.81. Referring to stock’s 52-week performance, its high was $4.36, and the low was $0.92. On the whole, MREO has fluctuated by -8.67% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MREO’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MREO currently trading nearly -7.34% and -15.74% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.86, while the 7-day volatility ratio is showing 5.04% which for the 30-day chart, stands at 6.08%. Furthermore, Mereo Biopharma Group Plc ADR (MREO)’s beta value is 0.83, and its average true range (ATR) is 0.17.
A comparison of Mereo Biopharma Group Plc ADR (MREO) with its peers suggests the former has fared considerably weaker in the market. MREO showed an intraday change of -2.49% in last session, and over the past year, it grew by 122.76%%.
Data on historical trading for Mereo Biopharma Group Plc ADR (NASDAQ:MREO) indicates that the trading volumes over the past 3 months, they’ve averaged 1.38 million. According to company’s latest data on outstanding shares, there are 140.06 million shares outstanding.
Nearly 0.00% of Mereo Biopharma Group Plc ADR’s shares belong to company insiders and institutional investors own 61.44% of the company’s shares. The stock has risen by 18.61% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MREO stock heading into the next quarter.
